Copovidone K25-31
4 organisations hold 4 active FDA Type IV Drug Master Files for Copovidone K25-31. 5 valid EDQM Certificates of Suitability are on record for the same substance.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology
Active Type IV DMFs (4)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH CO LTD China | 39828 | COPOVIDONE | Apr 2024 |
| BOAI NKY MEDICAL HOLDINGS LTD China | 36420 | COPOVIDONE | Nov 2021 |
| HUANGSHAN BONSUN PHARMACEUTICALS CO LTD | 33953 | COPOVIDONE | Jul 2019 |
| STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTD China | 29000 | COPOVIDONE | Jan 2015 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
Valid CEPs for this substance (5)
| Holder | Country | Certificate | Issued |
|---|---|---|---|
| BASF SE | DE | CEP 2007-106 - Rev 04 Copovidone, Nominal K-value 28 | Jun 2026 |
| HUANGSHAN BONSUN PHARMACEUTICALS CO., LTD. Huangshan CN | CN | CEP 2019-199 - Rev 01 Copovidone, K-value: 27.0-33.0 | Oct 2025 |
| BOAI NKY MEDICAL HOLDINGS LTD | CN | R0-CEP 2023-019 - Rev 00 Copovidone, K-value: 25.2-30.8 | Aug 2023 |
| STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTD | CN | R1-CEP 2014-365 - Rev 00 Copovidone, K-value: 25.2-30.8 | Feb 2021 |
| Ashland Industries Europe GmbH Schaffhausen CH | CH | R1-CEP 2010-086 - Rev 00 Copovidone, K-value: 25.2-30.8 | Jul 2017 |
Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Copovidone K25-31.
Do you supply Copovidone K25-31?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.